New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

August 2002

August 14

Lexapro (escitalopram oxalate) Tablets and Oral Solution

Date of Approval: August 14, 2002
Company: Forest Laboratories, Inc.
Treatment for: Depression, Generalized Anxiety Disorder

Lexapro (escitalopram oxalate) is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder and for the treatment of generalized anxiety disorder (GAD).

August 29

Lexapro (escitalopram oxalate)

New Indication Approved: August 29, 2002

December 2

Lexapro (escitalopram oxalate)

New Dosage Form Approved: November 27, 2002

December 18

Lexapro (escitalopram oxalate)

New Indication Approved: December 18, 2002

January 31

Eloxatin (oxaliplatin)

New Formulation Approved: January 31, 2005

March 20

Lexapro (escitalopram oxalate)

Patient Population Altered: March 20, 2009

Hide
(web2)